Your browser doesn't support javascript.
loading
COVID-19 with baricitinib-induced symptomatic creatinine kinase elevation.
Saishoji, Y; Izumi, Y; Otsuka, Y; Yura, H.
Affiliation
  • Saishoji Y; From the Department of General Internal Medicine, National Hospital Organization Nagasaki Medical Center, Kubara 2-1001-1, Omura, Nagasaki 856-8562, Japan.
  • Izumi Y; From the Department of General Internal Medicine, National Hospital Organization Nagasaki Medical Center, Kubara 2-1001-1, Omura, Nagasaki 856-8562, Japan.
  • Otsuka Y; From the Department of General Internal Medicine, National Hospital Organization Nagasaki Medical Center, Kubara 2-1001-1, Omura, Nagasaki 856-8562, Japan.
  • Yura H; Department of Respiratory disease, National Hospital Organization Nagasaki Medical Center, Kubara 2-1001-1, Omura, Nagasaki 856-8562, Japan.
QJM ; 115(3): 155-156, 2022 03 22.
Article in En | MEDLINE | ID: mdl-35026023
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Azetidines / COVID-19 Drug Treatment Type of study: Diagnostic_studies Limits: Humans Language: En Journal: QJM Journal subject: MEDICINA Year: 2022 Document type: Article Affiliation country: Japón
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Azetidines / COVID-19 Drug Treatment Type of study: Diagnostic_studies Limits: Humans Language: En Journal: QJM Journal subject: MEDICINA Year: 2022 Document type: Article Affiliation country: Japón